Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Clinical trial NCT02207530 · COMPLETED

Trial details

NCT number: NCT02207530
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent or Metastatic PD-L1-positive Squamous Cell Carcinoma of the Head and Neck

Start date: 2014-10-23
Primary completion: 2016-09-26
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.